2425-0402 Individual Placement Support

Location

London:

Description

The Individual Placement and Support (IPS) Drug and Alcohol Service in Islington is designed to help individuals aged 18 and over who have current or past drug or alcohol issues and are unemployed. The service aims to support these individuals in returning to employment through intensive, personalised support, rapid job searches, placement in paid employment, and ongoing support for both employees and employers. The IPS service model integrates employment and vocational services with drug and alcohol support, focusing on the needs of individuals seeking education or employment. It includes time-limited on-the-job training and post-placement support to help participants adjust to job demands and assist employers.

Total Quantity or Scope

The procurement for the Individual Placement and Support (IPS) Drug and Alcohol Service in Islington is governed by the Provider Selection Regime (PSR) regulations under CPV code ‘85312500-4 Rehabilitation services’. This service is uniquely designed for individuals who are open to receiving clinical support within the commissioned drug and alcohol treatment service. The IPS team is fully integrated into the core drug and alcohol treatment service, providing targeted support for the rehabilitation of those with substance use needs as part of a holistic approach. Additional information: This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally awarded using direct award process C.

Award Detail

Award Criteria

CPV Codes

• 85312500 - Rehabilitation services

Legal Justification

This was conducted under the Provider Selection Regime.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** This contract has been awarded under the Provider Selection Regime. A conflicts assessment was conducted and no conflicts or potential conflicts were identified. The contract period shall be from the commencement date of 23 April 20235 until 31 March 2026. There is an option to extend the contract by one period of up to twelve months to 31 March 2027.